Clinical Trial
Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease
- PMID: 6197105
Item in Clipboard
Clinical Trial
Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease
Birth Defects Orig Artic Ser.
1983.
No abstract available
Similar articles
-
[Treatment of primary immunodeficiencies with intravenous gamma globulin].An Esp Pediatr. 1987 Dec;27(6):411-5. An Esp Pediatr. 1987. PMID: 2451892 Spanish.
-
Intravenous gammaglobulin for immunodeficiency: report from The European Group for Immunodeficiencies (EGID).Clin Exp Immunol. 1986 Sep;65(3):683-90. Clin Exp Immunol. 1986. PMID: 2430746 Free PMC article. Clinical Trial.
-
Individualization of gamma globulin dosage in patients with humoral immunodeficiency.Birth Defects Orig Artic Ser. 1983;19(3):209-12. Birth Defects Orig Artic Ser. 1983. PMID: 6197106 No abstract available.
-
Intravenous gamma-globulin: clinical applications in pediatric care.J Pediatr Nurs. 1990 Oct;5(5):307-15. J Pediatr Nurs. 1990. PMID: 1698963 Review.
-
[The use of intravenous gamma globulin in malignant hematologic diseases].Medicina (B Aires). 1989;49(6):621-7. Medicina (B Aires). 1989. PMID: 2484842 Review. Spanish. No abstract available.
Cited by
-
1040 prophylactic infusions with an unmodified intravenous immunoglobulin product causing few side-effects in patients with antibody deficiency syndromes.Infection. 1985 May-Jun;13(3):102-10. doi: 10.1007/BF01642867. Infection. 1985. PMID: 4030106